Results 251 to 260 of about 4,582,351 (335)

Retrospective Clinical Investigation into the Association Between Abnormal Blood Clotting, Oral Anticoagulant Therapy, and Medium-Term Mortality in a Cohort of COVID-19 Patients. [PDF]

Biomedicines
Dinoi G, Togo MV, Guida P, Deruvo C, Samarelli F, Imbrici P, Nicolotti O, De Luca A, Mastroianni F, Liantonio A, Altomare CD.   +10 more
europepmc   +1 more source

Implementation of guidelines for intravenous iron therapy in heart failure patients

ESC Heart Failure, EarlyView.
Abstract Aims We aim to evaluate the implementation of the 2021 ESC Guidelines regarding screening and treatment of iron deficiency in patients with heart failure (HF) at Karolinska University Hospital. Methods and results Patients with left ventricular ejection fraction (LVEF) < 50% and New York Heart Association (NYHA) class II–IV who visited ...
Milou Gamage, Aristomenis Manouras, Camilla Hage, Gianluigi Savarese, Karin Ljung, Michael Melin   +5 more
wiley   +1 more source

Recurrent Acute Myocardial Infarction in a Patient with Severe Coronary Artery Ectasia Followed Up for 10 Years: Implications of Anticoagulant Therapy. [PDF]

Am J Case Rep
Liang M, Sun P, Li Y.
europepmc   +1 more source

Topical Anesthesia Cataract Surgery in Patients with Anticoagulant Therapy

, 2000
J.C. Quintyn, Emile Calenda, A Retout, Gérard Brasseur   +3 more
openalex   +1 more source

Identification, characterisation and outcomes of pre‐atrial fibrillation in heart failure with reduced ejection fraction

ESC Heart Failure, EarlyView.
Abstract Aims Atrial fibrillation (AF) in heart failure with reduced ejection fraction (HFrEF) has prognostic implications. Using a machine learning algorithm (FIND‐AF), we aimed to explore clinical events and the cardiac magnetic resonance (CMR) characteristics of the pre‐AF phenotype in HFrEF.
Anna Helbitz, Ramesh Nadarajah, Lan Mu, Harriet Larvin, Hesham Ismail, Ali Wahab, Patrick Thompson, Peter Harrison, Mohammad Harris, Tobin Joseph, Sven Plein, Mark Petrie, Marco Metra, Jianhua Wu, Peter Swoboda, Chris P. Gale   +15 more
wiley   +1 more source

Optimal Treatment of Non-traumatic Intracerebral Hemorrhage Associated with Anticoagulant Therapy

, 2000
Mikihiko Takeshita, Takakazu Kawamata, Toshiyuki Sasaki, Masahiro Izawa, Tomokatsu Hori   +4 more
openalex   +2 more sources

Angiotensin receptor‐neprilysin inhibitors in concurrent heart failure with reduced ejection fraction and kidney failure

ESC Heart Failure, EarlyView.
Abstract Aims Angiotensin receptor‐neprilysin inhibitor (ARNI) therapy has demonstrated improved outcomes in heart failure with reduced ejection fraction (HFrEF). However, its benefits in patients with concomitant kidney failure undergoing replacement therapy remain uncertain. Methods and results Using the National Health Insurance Service database, we
Mi‐Hyang Jung, Dong‐Hyuk Cho, Jimi Choi, Mi‐Na Kim, Chan Joo Lee, Jung‐Woo Son, Yaeni Kim, Jong‐Chan Youn, Byung‐Su Yoo   +8 more
wiley   +1 more source

Factor XI and XIa inhibition: a new approach to anticoagulant therapy. [PDF]

Br J Cardiol
Sammut MA, Elamin N, Storey RF.
europepmc   +1 more source